RossouwJE, AndersonGL, PrenticeRLet al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA, 2002; 288:321–333.
2.
HershAL, StefanickML, StaffordRS. National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA, 2004; 291:47–53.
3.
SantenRJ, AllredDC, ArdoinSPet al.Postmenopausal hormone therapy: An Endocrine Society scientific statement. J Clin Endocrinol Metab, 2010; 95:s1–s66.
4.
MaclennanAH, BroadbentJL, LesterS, MooreV. Oral oestrogen and combined oestrogen/progesterone therapy versus placebo for hot flushes. Cochrane Database Sys Rev, 2009.
5.
LammersPK. Menopause core curriculum study guide. Cleveland, OH: North American Menopause Society, 2002.
6.
Estrogen and progestogen use in postmenopausal women:. 2010 position statement of The North American Menopause Society. Menopause, 2010; 17:242–255.
7.
Haimov-KochmanR, Barak-GlantzE, ArbelRet al.Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: A randomized prospective study. Menopause, 2006; 13:370–376.
8.
LoprinziCL, SloanJ, StearnsVet al.Newer antidepressants and gabapentin for hot flashes: An individual patient pooled analysis. J Clin Oncol, 2009; 27:2831–2837.
9.
The role of soy isoflavones in menopausal health:. Report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL, October 2010. Menopause, 2011; 18:732–753.
10.
PachmanDR, JonesJM, LoprinziCL. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions. Int J Womens Health, 2010; 2:123–135.
